Even though clinical trials haven’t shown it works against COVID-19, doctors continue to prescribe ivermectin – and a new study suggests health insurers are heavily subsidizing the cost of those prescriptions. The study’s authors call for insurers to align their coverage of the drug with the level of medical evidence surroundingContinue Reading